Impact of interim progression during the surgery-to-radiotherapy interval and its predictors in glioblastoma treated with temozolomide-based radiochemotherapy.
作者： Chan Woo Wee , Eunji Kim , Tae Min Kim , Chul-Kee Park , Jin Wook Kim
DOI: 10.1007/S11060-017-2505-X
关键词: Medicine 、 Interim 、 Confounding 、 Temozolomide 、 Glioblastoma 、 Surgery 、 Neurology 、 Radiation therapy 、 Clinical trial 、 Multivariate analysis
摘要: This study was designed to investigate the impact of interim progression of disease (PD) during the surgery-to-radiotherapy interval (SRI) and its predictors in glioblastoma based on …
springer.com
sci-hub.st 参考文章(19)
Anne G. Osborn, Osborn's brain : imaging, pathology, and anatomy Published in <b>2013</b> in Salt Lake City Utah by Amirsys Pub. ,(2013)
Anne Line Stensjøen, Ole Solheim, Kjell Arne Kvistad, Asta K. Håberg, Øyvind Salvesen, Erik Magnus Berntsen, Growth dynamics of untreated glioblastomas in vivo Neuro-oncology. ,vol. 17, pp. 1402- 1411 ,(2015) , 10.1093/NEUONC/NOV029
Matthew Z. Sun, Taemin Oh, Michael E. Ivan, Aaron J. Clark, Michael Safaee, Eli T. Sayegh, Gurvinder Kaur, Andrew T. Parsa, Orin Bloch, Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma. Journal of Neurosurgery. ,vol. 122, pp. 1144- 1150 ,(2015) , 10.3171/2014.9.JNS14193
C. Pennington, L. Kilbride, R. Grant, J.M. Wardlaw, A pilot study of brain tumour growth between radiotherapy planning and delivery. Clinical Oncology. ,vol. 18, pp. 104- 108 ,(2006) , 10.1016/J.CLON.2005.09.004
Roger Stupp, Warren P. Mason, Martin J. van den Bent, Michael Weller, Barbara Fisher, Martin J.B. Taphoorn, Karl Belanger, Alba A. Brandes, Christine Marosi, Ulrich Bogdahn, Jürgen Curschmann, Robert C. Janzer, Samuel K. Ludwin, Thierry Gorlia, Anouk Allgeier, Denis Lacombe, J. Gregory Cairncross, Elizabeth Eisenhauer, René O. Mirimanoff, Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma The New England Journal of Medicine. ,vol. 352, pp. 987- 996 ,(2005) , 10.1056/NEJMOA043330
Mark R. Gilbert, James J. Dignam, Terri S. Armstrong, Jeffrey S. Wefel, Deborah T. Blumenthal, Michael A. Vogelbaum, Howard Colman, Arnab Chakravarti, Stephanie Pugh, Minhee Won, Robert Jeraj, Paul D. Brown, Kurt A. Jaeckle, David Schiff, Volker W. Stieber, David G. Brachman, Maria Werner-Wasik, Ivo W. Tremont-Lukats, Erik P. Sulman, Kenneth D. Aldape, Walter J. Curran, Minesh P. Mehta, A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma The New England Journal of Medicine. ,vol. 370, pp. 699- 708 ,(2014) , 10.1056/NEJMOA1308573
F-W Kreth, N Thon, M Simon, M Westphal, G Schackert, G Nikkhah, B Hentschel, G Reifenberger, T Pietsch, M Weller, J-C Tonn, German Glioma Network, Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy Annals of Oncology. ,vol. 24, pp. 3117- 3123 ,(2013) , 10.1093/ANNONC/MDT388
Mark R. Gilbert, Meihua Wang, Kenneth D. Aldape, Roger Stupp, Monika E. Hegi, Kurt A. Jaeckle, Terri S. Armstrong, Jeffrey S. Wefel, Minhee Won, Deborah T. Blumenthal, Anita Mahajan, Christopher J. Schultz, Sara Erridge, Brigitta Baumert, Kristen I. Hopkins, Tzahala Tzuk-Shina, Paul D. Brown, Arnab Chakravarti, Walter J. Curran, Minesh P. Mehta, Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial Journal of Clinical Oncology. ,vol. 31, pp. 4085- 4091 ,(2013) , 10.1200/JCO.2013.49.6968
Jenny Huang, Lisa Barbera, Melissa Brouwers, George Browman, William J. Mackillop, Does Delay in Starting Treatment Affect the Outcomes of Radiotherapy? A Systematic Review Journal of Clinical Oncology. ,vol. 21, pp. 555- 563 ,(2003) , 10.1200/JCO.2003.04.171
Esmaeil Mehrara, Eva Forssell-Aronsson, Håkan Ahlman, Peter Bernhardt, Specific growth rate versus doubling time for quantitative characterization of tumor growth rate. Cancer Research. ,vol. 67, pp. 3970- 3975 ,(2007) , 10.1158/0008-5472.CAN-06-3822